Phd Frederique Menzaghi Net Worth & Insider Trades

Phd Frederique Menzaghi - Chief Scientific OffSVP-R&D, Cara Therapeutics, Inc

As of December 23, 2022

What is Phd Frederique Menzaghi's Net Worth?

The current estimated net worth of Cara Therapeutics, Inc's Chief Scientific OffSVP-R&D, Phd Frederique Menzaghi, is estimated to be about $5.8M . Phd Frederique Menzaghi owns about 166,275 units of Cara Therapeutics, Inc common stock. In the last 8 years at Cara Therapeutics, Inc, Phd Frederique Menzaghi has sold an estimated value of $4.88M worth.

What is Phd Frederique Menzaghi's Past Insider Trading?

Phd Frederique Menzaghi's largest purchase order was 40,000 units , worth over $82K on November 5, 2018. Phd Frederique Menzaghi's largest sale order was 20,000 units , worth over $464.8K on August 5, 2019. In total, Phd Frederique Menzaghi has made about 56 transactions over 8 years of their time at Cara Therapeutics, Inc. Phd Frederique Menzaghi usually trades in March, with the busiest year in 2019. The most recent transaction was a sale order of 3,506 units , worth over $39.51K on December 23, 2022.

PhD Frederique Menzaghi

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Phd Frederique Menzaghi's' Mailing Address?

  • Mailing address is C/o Cara Therapeutics, Inc. 1 Parrott Drive Shelton CT 06484 CT

What are Cara Therapeutics, Inc's Past Insider Trades?

Cara Therapeutics, Inc's most recent insider trade came on January 19, 2023 by Joana Goncalves who sold 2,265 units worth $24.48K . In the last 9 years, insiders at Cara Therapeutics, Inc have sold an estimated value of $26.95M and bought an estimated value of $21.23M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Phd Frederique Menzaghi, Chief Scientific OffSVP-R&D,  Derek Chalmers, President & CEO,  and Joana Goncalves, Chief Medical Officer .

Cara Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1